Sign Out
Use in Pregnancy: Pregnancy Category D: Erlotinib has been shown to cause maternal toxicity with associated embryo/fetal lethality and abortion in rabbits when given at doses that result in plasma drug concentrations of approximately 3 times those in humans (AUCs at 150 mg daily dose).
No teratogenic effects were observed in rabbits or rats.
Continue with Google